Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...
The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...
The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.
University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...
Ovarian cancer reprograms the omentum to shield hidden tumors. New research suggests total omentectomy may curb recurrence and improve long-term outcomes.
A sponge-like gold nanoparticle platform could deliver faster, more accurate, and less invasive ovarian cancer diagnostics.
In Ovarian Cancer, Interval Debulking Surgery Leads to Fewer Complications, Does Not Affect Survival
In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...
DOCTOR, OVARIAN CANCER IS VERY TREATABLE IF CAUGHT EARLY. BUT HOW DO YOU CATCH SOMETHING IF YOU CAN’T FIND IT? MERCY MEDICAL CENTER, IS JOINING US NOW WITH SOME MORE INFORMATION. GOOD MORNING. THANKS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback